RHUMBLINE ADVISERS - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 261 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$3,197,898
-37.0%
382,984
+0.4%
0.00%
-33.3%
Q2 2023$5,075,160
+108506.0%
381,591
-5.4%
0.01%0.0%
Q1 2023$4,673
+59.1%
403,505
+12.4%
0.01%
+50.0%
Q4 2022$2,937
-99.9%
359,045
+1.8%
0.00%
+33.3%
Q3 2022$2,048,000
+40.7%
352,808
+7.1%
0.00%
+50.0%
Q2 2022$1,456,000
-32.4%
329,479
+39.1%
0.00%
-33.3%
Q1 2022$2,155,000
-57.0%
236,802
-3.4%
0.00%
-50.0%
Q4 2021$5,014,000
-20.9%
245,074
-1.3%
0.01%
-33.3%
Q3 2021$6,342,000
-27.4%
248,203
-0.6%
0.01%
-18.2%
Q2 2021$8,734,000
+21.7%
249,771
+15.9%
0.01%
+10.0%
Q1 2021$7,176,000
+23.5%
215,441
-3.8%
0.01%
+25.0%
Q4 2020$5,810,000
+199.8%
223,987
+14.0%
0.01%
+166.7%
Q3 2020$1,938,000
+165.5%
196,399
-7.1%
0.00%
+200.0%
Q2 2020$730,000
+22.7%
211,482
+8.8%
0.00%0.0%
Q1 2020$595,000
-42.6%
194,361
-3.5%
0.00%
-50.0%
Q4 2019$1,036,000
+1.3%
201,480
+1.6%
0.00%0.0%
Q3 2019$1,023,000
-13.7%
198,277
+1.2%
0.00%0.0%
Q2 2019$1,185,000
-9.1%
195,947
+8.6%
0.00%
-33.3%
Q1 2019$1,304,000
+0.7%
180,392
+3.1%
0.00%0.0%
Q4 2018$1,295,000
+117.3%
175,028
+59.0%
0.00%
+200.0%
Q3 2018$596,000
+43.6%
110,088
-5.9%
0.00%0.0%
Q2 2018$415,000
+102.4%
116,960
+17.0%
0.00%
Q1 2018$205,000
-23.2%
99,955
-1.1%
0.00%
-100.0%
Q4 2017$267,000
-53.2%
101,110
-6.9%
0.00%0.0%
Q3 2017$570,000
+53.2%
108,584
+3.8%
0.00%0.0%
Q2 2017$372,000
-29.4%
104,614
+2.6%
0.00%0.0%
Q1 2017$527,000
+39.8%
101,964
+2.7%
0.00%0.0%
Q4 2016$377,000
-54.6%
99,261
+7.1%
0.00%
-50.0%
Q3 2016$830,000
+32.8%
92,654
+4.3%
0.00%0.0%
Q2 2016$625,000
-4.6%
88,835
+15.3%
0.00%0.0%
Q1 2016$655,000
-31.5%
77,033
+5.8%
0.00%
-33.3%
Q4 2015$956,000
+298.3%
72,778
+10.9%
0.00%
+200.0%
Q3 2015$240,000
-46.5%
65,648
-15.8%
0.00%0.0%
Q2 2015$449,000
-0.2%
78,006
+1.3%
0.00%0.0%
Q1 2015$450,000
-13.1%
77,026
+16.5%
0.00%
-50.0%
Q4 2014$518,000
+93.3%
66,126
+21.3%
0.00%
+100.0%
Q3 2014$268,000
-22.3%
54,521
-2.3%
0.00%0.0%
Q2 2014$345,000
-5.7%
55,821
-18.5%
0.00%0.0%
Q1 2014$366,000
+1.4%
68,494
-0.9%
0.00%0.0%
Q4 2013$361,000
-8.6%
69,114
-3.4%
0.00%0.0%
Q3 2013$395,000
+118.2%
71,514
-0.6%
0.00%0.0%
Q2 2013$181,00071,9250.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q2 2021
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 1,446,459$48,182,0007.22%
BOURNE LENT ASSET MANAGEMENT INC 536,800$17,881,0005.70%
Casdin Capital, LLC 5,000,000$166,550,0004.96%
Iron Triangle Partners LP 935,805$31,172,0003.96%
Jackson Square Partners, LLC 12,911,695$430,088,0002.44%
SB Management Ltd 9,861,089$328,473,0002.12%
Abacus Planning Group, Inc. 180,000$5,996,0001.92%
BERKSHIRE CAPITAL HOLDINGS INC 413,800$13,784,0001.57%
ARK Investment Management 21,301,191$709,543,0001.41%
Nikko Asset Management Americas, Inc. 5,247,237$174,785,0000.86%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders